# Trade Mark Journal No.2026/030 24 July 2026

## WO0000001915509 (35,42,44,45)

Office of origin: Canada

Date of International Registration:21 January 2026
Date of designation in the UK: 21 January 2026

International priority date claimed: 25 July 2025 (Canada) (2413975)

Class 35
  Referrals in the field of testing laboratories for drug development programs; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; compiling data for research purposes in the field of medical science and medical consultancy.
Class 42
  Technical consulting in the field of pharmaceutical studies; consulting services in the field of pharmaceutical research; pharmaceutical drug development services; medical and scientific research in the field of radiopharmaceuticals; scientific research for medical purposes in the field of radiopharmaceuticals; medical and scientific research information in the field of radiopharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information about medical and scientific research; providing medical research information in the field of pharmaceuticals; technical writing.
Class 44
  Medical and pharmaceutical consultation.
Class 45
  Regulatory compliance consulting in the field of pharmaceuticals.

Centre for Probe Development and Commercialization

Representative: NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L.,S.R.L., 1, Place Ville Marie, Suite 2500, Montreal QUEBEC H3B 1R1, CANADA